Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Jul 29, 2026
Robinhood (HOOD) Pulls Back 8.9% Ahead of Q2 Earnings: Diversification in Focus

Robinhood (HOOD) Pulls Back 8.9% Ahead of Q2 Earnings: Diversification in Focus

Key Takeaways

  • Robinhood (HOOD) shares have pulled back approximately 8.9% over the past 30 days, trading near $92.76 as of late July 2026, ahead of the company's highly anticipated Q2 earnings report.
  • The launch of Robinhood Chain — an Ethereum Layer-2 blockchain — has driven rapid adoption, surpassing 328,000 real-world asset holders and attracting over $325 million in total value locked within its first month.
  • Prediction markets, led by the Rothera platform, have become a critical growth engine, with Bernstein forecasting segment revenue could reach $1.7 billion annually by 2028.
  • Several Wall Street analysts — including Bernstein, Needham, KeyBanc, and Goldman Sachs — have raised their price targets on HOOD in recent weeks, with targets ranging from $123 to $160.
  • Q2 2026 earnings, scheduled for July 29, represent a pivotal catalyst: consensus estimates call for revenue of roughly $1.21–$1.26 billion and EPS near $0.41, with crypto trading weakness expected to be offset by strength in equities, options, and prediction markets.
  • The stock remains down roughly 20% year-to-date, reflecting ongoing pressure from declining cryptocurrency transaction volumes and broader market uncertainty.

Where HOOD Stands in Late July 2026

Robinhood Markets (HOOD) heads into the final days of July 2026 with investor attention firmly fixed on its upcoming earnings. Shares have eased from around $101.83 at the end of June to approximately $92.76 as of July 28, marking an 8.9% pullback over the past month. Two competing stories are at play: strong early traction for new offerings such as Robinhood Chain and prediction markets versus ongoing softness in crypto trading volumes. With results due after the close on July 29, the market is assessing whether the company’s push into new areas can counterbalance crypto-related headwinds. The shares sit well below the 52-week high of $153.86 yet remain up 44.7% from the March low near $63.51.

Robinhood’s Business and Competitive Landscape

Robinhood Markets is a Menlo Park-based fintech firm that pioneered commission-free trading for retail investors. The platform now serves roughly 27.4 million funded customers, providing access to equities, ETFs, options, futures, and cryptocurrencies, as well as digital banking, retirement accounts, wealth management, and the Robinhood Gold subscription. The company has moved beyond its brokerage roots into prediction markets through the Rothera platform (built on the LedgerX acquisition), blockchain infrastructure via Robinhood Chain, and even a social feature called Robinhood Social. With a market capitalization near $85 billion, it competes directly with established players such as Charles Schwab (SCHW) and Interactive Brokers (IBKR), while also facing competition from crypto-focused firms like Coinbase (COIN). I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Recent Developments Shaping the Stock

The standout development over the past 30 days has been the launch of Robinhood Chain, an Arbitrum-based Ethereum Layer-2 network that went live in late June. It quickly became the largest blockchain by real-world asset holders, surpassing both Solana and Ethereum with approximately 328,000 RWA holders and $325 million in total value locked. CEO Vlad Tenev noted that the network “works well for memes,” which sparked an initial wave of decentralized exchange activity that has since moderated.

Prediction markets have emerged as another key growth area. June marked a record month for event contracts, aided by World Cup interest, and the Rothera platform now accounts for about 16% of total event-contract volume. Bernstein raised its price target to $160 on July 21, highlighting a 64% compound annual growth path for prediction markets through 2028.

Analyst sentiment has improved overall. Needham increased its target from $97 to $123, KeyBanc moved from $100 to $125, and Goldman Sachs lifted its target to $137. Compass Point raised its target to $130 in early July, anticipating an 18% EBITDA beat. The CLARITY Act, which could bring regulatory clarity to digital assets, has also been viewed as a potential positive.

Offsetting some of the optimism, crypto transaction revenue stayed under pressure—down 47% year-over-year in Q1—and the company announced a 10% workforce reduction on June 16 to manage costs. Activity on Robinhood Chain has cooled somewhat, with daily active accounts falling 7% and trading volume per active account declining from a peak of $2,800 to roughly $2,000. From what I see, these metrics will be worth watching closely after earnings.

2026 Outlook and Key Areas to Monitor

The immediate focus remains Q2 earnings on July 29. Beyond the headline figures, attention will turn to management’s guidance on operating expenses, projected at $2.7–$2.825 billion for the full year, including roughly $100 million tied to the Trump Accounts child-investment initiative. The durability of prediction-market revenue growth, the path of Robinhood Chain adoption beyond its initial meme-coin phase, and any signs of a crypto trading recovery will shape the second-half story.

Over the longer term, tokenized securities represent a multi-year opportunity. Bernstein estimates the total value of blockchain-based real-world assets could grow from roughly $35 billion today to between $2 trillion and $4 trillion by the end of the decade, positioning Robinhood Chain as an important infrastructure player. The SpaceX IPO, for which Robinhood was chosen as a distribution platform, and the continued rollout of Trump Accounts also offer potential revenue drivers. Key risks include sustained cryptocurrency market weakness, regulatory uncertainty around prediction markets and perpetuals, and the stock’s valuation at roughly 37 times forward earnings, which requires consistent execution.

Exploring AI-Powered Trading Strategies

I’ve found it useful to review automated strategies alongside traditional analysis. Tickeron’s Trending AI Robots page highlights top-performing AI-powered trading bots from hundreds of strategies across thousands of tickers. These bots apply machine learning and technical analysis to spot opportunities on different timeframes, with transparent metrics like win rate, drawdown, and Sharpe ratio. For a name like HOOD, checking which automated approaches are currently showing strength can add another layer to the research process.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: HOOD

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


HOOD's Indicator enters downward trend

The Aroon Indicator for HOOD entered a downward trend on August 11, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 209 similar instances where the Aroon Indicator formed such a pattern. In of the 209 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for HOOD turned negative on July 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

HOOD moved below its 50-day moving average on July 24, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for HOOD crossed bearishly below the 50-day moving average on July 31, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HOOD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HOOD's RSI Indicator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 11, 2026. You may want to consider a long position or call options on HOOD as a result. In of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 50-day moving average for HOOD moved above the 200-day moving average on August 07, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HOOD advanced for three days, in of 316 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HOOD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.953) is normal, around the industry mean (4.225). P/E Ratio (41.761) is within average values for comparable stocks, (21.556). Projected Growth (PEG Ratio) (2.142) is also within normal values, averaging (1.672). Dividend Yield (0.000) settles around the average of (0.033) among similar stocks. P/S Ratio (17.606) is also within normal values, averaging (31.137).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HOOD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 13B. The market cap for tickers in the group ranges from 13 to 928.5B. PKRSF holds the highest valuation in this group at 928.5B. The lowest valued company is BFCH at 13.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was 1%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was -10%. DOMH experienced the highest price growth at 23%, while VIP experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was -6%. For the same stocks of the Industry, the average monthly volume growth was -14% and the average quarterly volume growth was -52%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 63
P/E Growth Rating: 70
Price Growth Rating: 63
SMR Rating: 76
Profit Risk Rating: 85
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
HOOD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry InvestmentBanksBrokers

Profile
Details
Industry
N/A
Address
85 Willow Road
Phone
+1 844 428-5411
Employees
2900
Web
https://www.robinhood.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.